0001209191-17-001579.txt : 20170104
0001209191-17-001579.hdr.sgml : 20170104
20170104200741
ACCESSION NUMBER: 0001209191-17-001579
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170101
FILED AS OF DATE: 20170104
DATE AS OF CHANGE: 20170104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChemoCentryx, Inc.
CENTRAL INDEX KEY: 0001340652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943254365
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-210-2900
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cappel Markus J.
CENTRAL INDEX KEY: 0001422995
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35420
FILM NUMBER: 17508229
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-01-01
0
0001340652
ChemoCentryx, Inc.
CCXI
0001422995
Cappel Markus J.
C/O CHEMOCENTRYX, INC.
850 MAUDE AVENUE
MOUNTAIN VIEW
CA
94043
0
1
0
0
Chief Bus. Officer & Treasurer
Common Stock
2017-01-01
4
M
0
8333
0.00
A
20833
D
Common Stock
2017-01-01
4
F
0
4442
7.40
D
16391
D
Common Stock
2017-01-03
4
M
0
26821
4.30
A
43212
D
Common Stock
2017-01-03
4
S
0
26821
7.5055
D
16391
D
Restricted Stock Units
2017-01-01
4
M
0
8333
D
Common Stock
8333
16667
D
Stock Option (right to buy)
4.30
2017-01-03
4
M
0
26821
D
2007-02-06
2017-02-06
Common Stock
26821
0
D
Shares were acquired upon vesting of restricted stock units awarded on March 7, 2016.
Represents shares withheld upon vesting of restricted stock units to satisfy tax withholding obligation.
The sales reported in this Form 4 were effected pursuant to a June 2016 Rule 10b5-1 trading plan adopted by the Reporting Person.
Shares sold are associated with stock options which will expire in February 2017.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.50 to $7.59 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
The restricted stock units vest in three equal installments on January 1, 2017, January 1, 2018, and January 1, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer through each such vesting date. Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.
As of January 3, 2017, and prior to this transaction, the option fully vested.
Not applicable.
/s/ Susan M. Kanaya, as Attorney-in-Fact
2017-01-04